SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-059626
Filing Date
2011-03-09
Accepted
2011-03-08 20:20:31
Documents
5
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1218018
2 CONSENT OF KPMG LLP dex231.htm EX-23.1 2719
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9361
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9352
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 6188
  Complete submission text file 0001193125-11-059626.txt   1246839
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22873 | Film No.: 11673460
SIC: 2835 In Vitro & In Vivo Diagnostic Substances